Fulltext

A meta-analysis on the preadmission use of DPP-4 inhibitors and risk of a fatal or severe course of illness in patients with COVID-19

Kow CS 1 , Hasan SS 2

Affiliations 

  • 1 School of Postgraduate Studies, International Medical University, No. 126, Jalan Jalil Perkasa 19, Bukit Jalil, 57000 Kuala Lumpur, Malaysia. Electronic address: chiasiang_93@hotmail.com
  • 2 Department of Pharmacy, University of Huddersfield, HD1 3DH Queensgate, Huddersfield, United Kingdom; School of Biomedical Sciences & Pharmacy, University of Newcastle, University Drive, Callaghan, NSW 2308, Australia
Therapie, 2021;76(4):361-364.
PMID: 33423787 DOI: 10.1016/j.therap.2020.12.015

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications